These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 24821172)
1. Statin-associated acute interstitial nephritis and rhabdomyolysis. Panchangam V Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172 [No Abstract] [Full Text] [Related]
2. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction. Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661 [TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. Castro JG; Gutierrez L Am J Med; 2002 Apr; 112(6):505. PubMed ID: 11959068 [No Abstract] [Full Text] [Related]
5. [Rhabdomyolysis associated to combined ezetimibe-statin treatment]. Piedra León M; García Unzueta MT; Otero Martínez M; Amado Señaris JA Rev Clin Esp; 2007 Sep; 207(8):425-6. PubMed ID: 17688879 [No Abstract] [Full Text] [Related]
6. Rhabdomyolysis with concurrent atorvastatin and diltiazem. Lewin JJ; Nappi JM; Taylor MH Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603 [TBL] [Abstract][Full Text] [Related]
7. Hypernatremia due to rhabdomyolysis in a patient on statin. Victor SM; Gnanaraj A; Abraham G; Sankardas MA Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1037-8. PubMed ID: 21912045 [No Abstract] [Full Text] [Related]
8. [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy]. Rubí S; Duch J; Ortín J; Setoain X; Pons F Rev Esp Med Nucl; 2006; 25(6):393. PubMed ID: 17173790 [No Abstract] [Full Text] [Related]
9. Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Golomb B; Evans M Drug Saf; 2006; 29(12):1191; author reply 1191-2. PubMed ID: 17147465 [No Abstract] [Full Text] [Related]
10. Rhabdomyolysis with atorvastatin and fusidic acid. O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925 [TBL] [Abstract][Full Text] [Related]
11. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy. Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749 [No Abstract] [Full Text] [Related]
12. Unexpected observation of glomerular crescents in a patient with diabetes who developed drug-induced acute tubulointerstitial nephritis: A possible feature of diabetic nephropathy? Wakabayashi N; Takeda S; Imai T; Akimoto T; Nagata D Nephrology (Carlton); 2015 Jun; 20(6):438-9. PubMed ID: 25900387 [No Abstract] [Full Text] [Related]
13. [Metabolic rhabdomyolysis during statin therapy]. Vergely N; Leca V; Antoine JC; Germain N; Khalfallah Y; Estour B Rev Med Interne; 2009 Aug; 30(8):711-3. PubMed ID: 19419805 [TBL] [Abstract][Full Text] [Related]
14. Pooled RCTs: atorvastatin did not increase renal-related serious adverse events. Herrington W; Haynes R Ann Intern Med; 2014 Oct; 161(8):JC8. PubMed ID: 25329225 [No Abstract] [Full Text] [Related]
15. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine. Maltz HC; Balog DL; Cheigh JS Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315 [TBL] [Abstract][Full Text] [Related]
16. Intensive lipid lowering with atorvastatin in coronary disease. Ravnskov U; Rosch PJ; Sutter MC N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003834 [No Abstract] [Full Text] [Related]
17. Statin-associated rhabdomyolysis: is there a dose-response relationship? Holbrook A; Wright M; Sung M; Ribic C; Baker S Can J Cardiol; 2011; 27(2):146-51. PubMed ID: 21459261 [TBL] [Abstract][Full Text] [Related]
18. A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis. Noordally SO; Sohawon S; Vanderhulst J; Duttmann R; Corazza F; Devriendt J Ann Saudi Med; 2012; 32(3):309-11. PubMed ID: 22588445 [TBL] [Abstract][Full Text] [Related]
19. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for rhabdomyolysis with simvastatin and atorvastatin. Ronaldson KJ; O'Shea JM; Boyd IW Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]